FT. WORTH, TX - March 15, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO, Inc. (OTCBB:EVCA) (Pinksheets:EVCA) announced today that well known electric vehicle marketing expert, Richard H Griffiths, has accepted the position of Chief Communications Officer. Mr. Griffiths, http://en.wikipedia.org/wiki/Richard_H._Griffiths, is an electric vehicle marketing expert as well as a Senior Government Advisor for the U.S. State Department, Government of Colombia, Republic of Tanzania and the Kingdom of Thailand. He will develop strategic relationships with governments, Hollywood celebrities and persons of influence in North America and globally. Mr. Griffiths has been successful in getting electric vehicles on media shows such as Regis and Kelly, FOX, CNN and was featured on the History Channel as one of the early pioneers of electric vehicles.

Mack Sanders, CEO of EVCARCO, stated, "Richard's work in getting New York City to place electric powered taxi cabs throughout the City, as well as his placement of electric smart cars for sale through Sam's Club, has earned him a reputation in the alternate fuel industry. Having Richard head up the Ambassador of Sustainability program will enable us to have a dialogue with Hollywood stars and will give our brand the attention required to get consumer and investor interest."

Mr. Griffiths stated, "It is an honor to be associated with EVCARCO. The team assembled at EVCA has a high level of experience in this field and will be focused on bringing the very best alternative energy vehicles to market."

For more information on EVCARCO, Inc., please view: www.evcarco.com. Shareholder inquiries should be directed to (972) 571-1624.

EVCARCO Inc. is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles.

This Press Release contains certain forward-looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.